The role of CD4+ T cells in experimental conjunctivitis was assessed in mice treated with a depleting anti-CD4 Ab (GK1.5) 6 days prior to ocular OVA challenge and again on the day of challenge. This evidence concerns the gene CD4 and conjunctivitis.